Page last updated: 2024-09-04

diquafosol and nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii)

diquafosol has been researched along with nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii) in 1 studies

Compound Research Comparison

Studies
(diquafosol)
Trials
(diquafosol)
Recent Studies (post-2010)
(diquafosol)
Studies
(nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii))
Trials
(nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii))
Recent Studies (post-2010) (nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii))
1263892603

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camden, J; Fischer, B; Weisman, GA; Yelovitch, S1

Other Studies

1 other study(ies) available for diquafosol and nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii)

ArticleYear
Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
    Journal of medicinal chemistry, 2012, Jan-12, Volume: 55, Issue:1

    Topics: Animals; Boranes; Calcium; Cell Line, Tumor; Dinucleoside Phosphates; Drug Stability; Humans; Hydrolysis; Models, Molecular; Molecular Conformation; Phosphoric Diester Hydrolases; Purinergic P2Y Receptor Agonists; Pyrophosphatases; Receptors, Purinergic P2Y; Stereoisomerism; Structure-Activity Relationship; Turkey

2012